HHS to address Lyme disease

The U.S. Department of Health and Human Services has announced a multi-faceted plan to reduce Lyme disease cases by 25% over the next decade, including new research, partnerships, and tick control efforts.

The U.S. Department of Health and Human Services (HHS) has announced several actions that will be taken to address Lyme disease. They hope to lower cases by 25% in the next decade.

The campaign will also cover other tick-borne illnesses and involve a largely funded pilot program. Through the program, HHS, the Centers for Disease Control and Prevention (CDC), and tick-control experts will discuss and test ways to remove ticks on wildlife.

Furthermore, a partnership between companies and the National Institutes of Health (NIH) is working to shield tick bite victims from developing Alpha-gal syndrome by getting effective products out.

Additional aspects of this campaign include:

  • New LymeX innovation challenges that will provide “up to $2.5 million in total prize funding to accelerate breakthroughs in public awareness, treatment, and patient care.”
  • A $10 million Diagnostics Prize to enhance Lyme Disease testing
  • A partnership between HHS and the International Lyme and Associated Diseases Society (ILADS)
  • The reauthorization of the bipartisan Kay-Hagan Tick Act

About the Author

Erin Brady

Managing Editor

Erin Brady is Managing Editor of Medical Laboratory Observer.

Sign up for our eNewsletters
Get the latest news and updates